| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.21 | 0.02 |